APOE and Alzheimer disease: Furthermore, our results are solely based on the APP23 model and may differ in other transgenic AD models, as highlighted by sex-specific metabolic alterations in models like triple-transgenic AD or E4FAD (human APOE4 and five familial AD mutations) females [84, 85].